Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor and epidermal growth factor.
Culig
Z
Z
Department of Urology, University of Innsbruck, Austria.
Hobisch
A
A
Cronauer
M V
MV
Radmayr
C
C
Trapman
J
J
Hittmair
A
A
Bartsch
G
G
Klocker
H
H
D015500:Chloramphenicol O-Acetyltransferase / Q000235:genetics / Q000378:metabolism; D004815:Epidermal Growth Factor / Q000494:pharmacology; D051526:Fibroblast Growth Factor 10; D051523:Fibroblast Growth Factor 7; D005346:Fibroblast Growth Factors; D015972:Gene Expression Regulation, Neoplastic; D006133:Growth Substances / Q000494:pharmacology*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology; D008297:Male; D011401:Promoter Regions, Genetic; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D011944:Receptors, Androgen / Q000235:genetics*; D015398:Signal Transduction; D015533:Transcriptional Activation; D014407:Tumor Cells, Cultured / Q000201:enzymology / Q000378:metabolism
C496453:FGF7 protein, human; D051526:Fibroblast Growth Factor 10; D006133:Growth Substances; D011944:Receptors, Androgen; D051523:Fibroblast Growth Factor 7; D005346:Fibroblast Growth Factors; D004815:Epidermal Growth Factor; D007334:Insulin-Like Growth Factor I; D015500:Chloramphenicol O-Acetyltransferase